-
Mashup Score: 2
Disparities in cancer research persist around the world. This is especially true in global health research, where high-income countries (HICs) continue to set global health priorities further creating several imbalances in how research is conducted in low and middle-income countries (LMICs). Cancer research disparities in Africa can be attributed to a vicious cycle of challenges in the research…
Source: BMJ Global HealthCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 5
Welcome! You are invited to join a meeting: National Cancer Summit (2-4 February 2023). After registering, you will receive a confirmation email about joining the meeting.
Source: ZoomCategories: Latest Headlines, Oncologists1Tweet-
RT @CANCERKESHO: Use the link shared below to virtually attend the ongoing #NationalCancerSummit2023 today. đź“Ť https://t.co/bJtLhXF39y
-
-
Mashup Score: 0The National Cancer Institute of Kenya - NCI Kenya - 1 year(s) ago
Web site created using create-react-app
Source: cancersummit.ncikenya.or.keCategories: Latest Headlines, Oncologists1Tweet-
The field of cancer (oncology) is growing rapidly in Kenya. Come and learn the steps taken so far and what can be done. Join us tomorrow for the first National Cancer Summit at Safari Park hotel in Nairobi. You can register here: https://t.co/jUx32RbKyv @CANCERKESHO @karagualf https://t.co/Ds4yXB4Xfr
-
-
Mashup Score: 1cAttendee - 1 year(s) agoSource: cattendee.abstractsonline.comCategories: Latest Headlines, Oncologists1Tweet
-
Ongoing Updates in the management of IBC by @ABCGlobalAll lead by Fatima Cardoso. Register here https://t.co/ESKjr8w1bN https://t.co/ylxBVEpUxq
-
-
Mashup Score: 8Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT - PubMed - 1 year(s) ago
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to dissemina …
Source: PubMedCategories: Latest Headlines, Oncologists1Tweet-
RT @FilippoMontemu1: Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT https://t.co/YLZOZwbkVW 12-year f…
-
-
Mashup Score: 4
Welcome! You are invited to join a webinar: MANAGEMENT OF METASTATIC NON-SMALL CELL LUNG CANCER -Dr Omar Abdihamid. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Latest Headlines, Oncologists1Tweet-
RT @HamidMD10: Starting in 30 minutes. Join us https://t.co/t3YK9R5PJE https://t.co/eNitGcVCGu
-
-
Mashup Score: 25Phase 2 Evaluation of Neoadjuvant Radiotherapy in Centrally Located Hepatocellular Carcinoma - 2 year(s) ago
This nonrandomized controlled trial evaluates the overall and disease-free survival rates as well as adverse events associated with combined neoadjuvant intensity-modulated radiotherapy and hepatectomy.
Source: jamanetwork.comCategories: Latest Headlines, Oncologists1Tweet-
RT @ArndtVogel: 🔥Phs-II of neoadjuvant intensity-modulated radiotherapy in #HCC🔥 @JAMASurgery https://t.co/LtCmTPubSC 👉IMRT -> 39pts. main…
-
-
Mashup Score: 1Postoperative radiotherapy for breast cancer: hypofractionation RCR consensus statements | The Royal College of Radiologists - 2 year(s) ago
The Royal College of Radiologist’s (RCR) 2016 breast consensus statements made recommendations on hypofractionation. There was consensus, with strong support, that there was no indication to use more than 15 fractions for the breast, chest wall or nodal areas. Following the FAST-Forward trial primary endpoint publication, the following statements were agreed in 2020 are intended to supplement the…
Source: www.rcr.ac.ukCategories: Latest Headlines, Oncologists1Tweet-
RT @radioncoluis: Postoperative radiotherapy for breast cancer: hypofractionation RCR consensus statements. https://t.co/nYXIro9BNF https:/…
-
-
Mashup Score: 5Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape - PubMed - 2 year(s) ago
Immune checkpoint inhibitors (ICI) can have significant anticancer activity, and are approved for many different cancer types, including breast cancer. In breast cancer, programmed cell death 1 (PD-1) inhibitors in combination with chemotherapy have demonstrated significant clinical benefit in early …
Source: PubMedCategories: Latest Headlines, Oncologists1Tweet-
RT @radioncoluis: Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape. https://t.co/eu89XQDKsM htt…
-
-
Mashup Score: 8
In patients with resected non-low-risk DCIS, a tumour bed boost after WBI reduced local recurrence with an increase in grade 2 or greater toxicity. The results provide the first randomised trial data to support the use of boost radiation after postoperative WBI in these patients to improve local control. The international scale of the study supports the generalisability of the results.
Source: The LancetCategories: Latest Headlines, Oncologists1Tweet-
RT @GavinPJonesMD: 📢 Just published, phase III BIG 3-07 DCIS boost trial in @TheLancet https://t.co/0Ykfy4e53W 👇16 Gy/8 fx boost in non-l…
-
Dear Colleagues, I am glad to share our latest article on Cancer Research in Africa where we describe the challenges including parachutism and possible solutions. Many thanks to @Rubagumyaf for making this possible. https://t.co/29IX4E6VNi @CANCERKESHO @OncoAlert @nazik_hammad https://t.co/ovyKrFIFWA